Delivery Order SPE2DB20D3505-SPE2DB23FT3Q1
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Eliquis 5 mg tablets to the U.S. government. The $3,969.61 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,258.30 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of May 11, 2023. The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,417.50 for the pharmaceutical product Eliquis 5 mg tablet 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 29, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,041.31 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 21, 2022. This award is under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,102.94 for the pharmaceutical product Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a firm fixed price of $50,626.84 for providing Eliquis 5 mg tablets. The award was made by the Defense Logistics Agency, a defense agency within the Department of Defense, and does not have a set-aside designation. The contract has an ultimate completion date of February 22, 2024 and is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,149.52 for the supply of Eliquis 5 mg tablets. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 2, 2024. This award is not associated with a set-aside program and is issued under an existing Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which has a ceiling...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $53,373.99 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $12,372.75 for the supply of the prescription drug Eliquis 5 mg tablet 60s. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of March 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,505.36 for the supply of Eliquis 5 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT3Q1Delivery Order
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order with a ceiling value of $6,931.42 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 29, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 11/28/22 |